Active 0 6 0 6 O
uncontrolled 7 19 7 19 O
infection 20 29 20 29 B-chronic_disease
or 30 32 30 32 O
severe 33 39 33 39 O
systemic 40 48 40 48 O
infection 49 58 49 58 O
( 59 60 59 60 O
enrollment 60 70 60 70 O
is 71 73 71 73 O
possible 74 82 74 82 O
after 83 88 83 88 O
control 89 96 89 96 O
of 97 99 97 99 O
infection 100 109 100 109 O
) 109 110 109 110 O

Adequate 0 8 111 119 O
organ 9 14 120 125 O
function 15 23 126 134 O
within 24 30 135 141 O
14 31 33 142 144 B-upper_bound
days 34 38 145 149 I-upper_bound
of 39 41 150 152 O
study 42 47 153 158 O
registration 48 60 159 171 O

Any 0 3 172 175 O
history 4 11 176 183 O
of 12 14 184 186 O
epilepsy 15 23 187 195 B-chronic_disease
or 24 26 196 198 O
a 27 28 199 200 O
seizure 29 36 201 208 B-chronic_disease
disorder 37 45 209 217 I-chronic_disease
or 46 48 218 220 O
any 49 52 221 224 O
known 53 58 225 230 O
prior 59 64 231 236 O
seizures 65 73 237 245 B-chronic_disease

Confirmation 0 12 246 258 O
that 13 17 259 263 O
the 18 21 264 267 O
subject 22 29 268 275 O
is 30 32 276 278 O
not 33 36 279 282 B-pregnancy
pregnant 37 45 283 291 I-pregnancy
must 46 50 292 296 O
be 51 53 297 299 O
established 54 65 300 311 O
by 66 68 312 314 O
a 69 70 315 316 O
negative 71 79 317 325 B-pregnancy
serum 80 85 326 331 I-pregnancy
beta 86 90 332 336 I-pregnancy
- 90 91 336 337 I-pregnancy
human 91 96 337 342 I-pregnancy
chorionic 97 106 343 352 I-pregnancy
gonadotropin 107 119 353 365 I-pregnancy
( 120 121 366 367 I-pregnancy
beta 121 125 367 371 I-pregnancy
- 125 126 371 372 I-pregnancy
hCG 126 129 372 375 I-pregnancy
) 129 130 375 376 I-pregnancy
pregnancy 131 140 377 386 I-pregnancy
test 141 145 387 391 O
result 146 152 392 398 O
obtained 153 161 399 407 O
during 162 168 408 414 O
screening 169 178 415 424 O

Confirmed 0 9 425 434 O
histologic 10 20 435 445 O
diagnosis 21 30 446 455 O
on 31 33 456 458 O
bone 34 38 459 463 B-treatment
marrow 39 45 464 470 I-treatment
biopsy 46 52 471 477 I-treatment
and 53 56 478 481 O
aspirate 57 65 482 490 O
within 66 72 491 497 O
28 73 75 498 500 B-upper_bound
days 76 80 501 505 I-upper_bound
of 81 83 506 508 O
trial 84 89 509 514 O
entry 90 95 515 520 O
prior 96 101 521 526 O
to 102 104 527 529 O
starting 105 113 530 538 O
cycle 114 119 539 544 O
1 120 121 545 546 O

Diagnosis 0 9 547 556 O
of 10 12 557 559 O
MDS 13 16 560 563 B-cancer
/ 16 17 563 564 O
CMML 17 21 564 568 B-cancer
that 22 26 569 573 O
is 27 29 574 576 O
refractory 30 40 577 587 O
to 41 43 588 590 O
or 44 46 591 593 O
intolerant 47 57 594 604 O
to 58 60 605 607 O
standard 61 69 608 616 B-treatment
therapy 70 77 617 624 I-treatment
and 78 81 625 628 O
is 82 84 629 631 O
no 85 87 632 634 O
longer 88 94 635 641 O
likely 95 101 642 648 O
to 102 104 649 651 O
respond 105 112 652 659 O
to 113 115 660 662 O
such 116 120 663 667 O
therapy 121 128 668 675 O
( 129 130 676 677 O
at 130 132 677 679 O
least 133 138 680 685 O
one 139 142 686 689 O
line 143 147 690 694 O
of 148 150 695 697 O
therapy 151 158 698 705 O
) 158 159 705 706 O

ECOG 0 4 707 711 B-clinical_variable
performance 5 16 712 723 I-clinical_variable
status 17 23 724 730 I-clinical_variable
of 24 26 731 733 O
0 27 28 734 735 B-lower_bound
, 28 29 735 736 O
1 30 31 737 738 O
or 32 34 739 741 O
2 35 36 742 743 B-upper_bound

Grade 0 5 744 749 B-chronic_disease
3 6 7 750 751 I-chronic_disease
peripheral 8 18 752 762 I-chronic_disease
neuropathy 19 29 763 773 I-chronic_disease
within 30 36 774 780 O
14 37 39 781 783 B-upper_bound
days 40 44 784 788 I-upper_bound
before 45 51 789 795 O
enrollment 52 62 796 806 O

Intrathecal 0 11 807 818 B-treatment
methotrexate 12 24 819 831 I-treatment
is 25 27 832 834 O
allowed 28 35 835 842 O
prior 36 41 843 848 O
to 42 44 849 851 O
and 45 48 852 855 O
during 49 55 856 862 O
treatment 56 65 863 872 O
per 66 69 873 876 O
investigator 70 82 877 889 O
discretion 83 93 890 900 O

Known 0 5 901 906 O
immediate 6 15 907 916 O
or 16 18 917 919 O
delayed 19 26 920 927 O
hypersensitivity 27 43 928 944 O
reaction 44 52 945 953 O
or 53 55 954 956 O
idiosyncrasy 56 68 957 969 O
to 69 71 970 972 O
drugs 72 77 973 978 O
chemically 78 88 979 989 O
related 89 96 990 997 O
to 97 99 998 1000 O
IGF 100 103 1001 1004 B-allergy_name
or 104 106 1005 1007 O
methotrexate 107 119 1008 1020 B-allergy_name

Male 0 4 1021 1025 B-gender
and 5 8 1026 1029 I-gender
female 9 15 1030 1036 I-gender
patients 16 24 1037 1045 I-gender
with 25 29 1046 1050 O
reproductive 30 42 1051 1063 O
potential 43 52 1064 1073 O
must 53 57 1074 1078 O
use 58 61 1079 1082 B-contraception_consent
an 62 64 1083 1085 I-contraception_consent
approved 65 73 1086 1094 I-contraception_consent
contraceptive 74 87 1095 1108 I-contraception_consent
method 88 94 1109 1115 I-contraception_consent
if 95 97 1116 1118 O
appropriate 98 109 1119 1130 O

Negative 0 8 1131 1139 B-pregnancy
serum 9 14 1140 1145 I-pregnancy
pregnancy 15 24 1146 1155 I-pregnancy
test 25 29 1156 1160 O
in 30 32 1161 1163 O
females 33 40 1164 1171 B-gender

Patients 0 8 1172 1180 O
with 9 13 1181 1185 O
active 14 20 1186 1192 B-chronic_disease
extramedullary 21 35 1193 1207 I-chronic_disease
disease 36 43 1208 1215 I-chronic_disease

Platelets 0 9 1216 1225 B-clinical_variable
> 10 11 1226 1227 O
10 12 14 1228 1230 B-lower_bound
x 15 16 1231 1232 I-lower_bound
10 17 19 1233 1235 I-lower_bound
^ 19 20 1235 1236 I-lower_bound
9 20 21 1236 1237 I-lower_bound
/ 21 22 1237 1238 I-lower_bound
L 22 23 1238 1239 I-lower_bound

Pregnancy 0 9 1240 1249 B-pregnancy
testing 10 17 1250 1257 O
is 18 20 1258 1260 O
not 21 24 1261 1264 O
required 25 33 1265 1273 O
for 34 37 1274 1277 O
post 38 42 1278 1282 O
- 42 43 1282 1283 O
menopausal 43 53 1283 1293 O
or 54 56 1294 1296 O
surgically 57 67 1297 1307 O
sterilized 68 78 1308 1318 O
women 79 84 1319 1324 B-gender

Pregnant 0 8 1325 1333 B-pregnancy
or 9 11 1334 1336 O
breastfeeding 12 25 1337 1350 O

Prior 0 5 1351 1356 B-treatment
systemic 6 14 1357 1365 I-treatment
chemotherapy 15 27 1366 1378 I-treatment
, 27 28 1378 1379 O
immunotherapy 29 42 1380 1393 B-treatment
, 42 43 1393 1394 O
or 44 46 1395 1397 O
biological 47 57 1398 1408 B-treatment
therapy 58 65 1409 1416 I-treatment
, 65 66 1416 1417 O
radiation 67 76 1418 1427 B-treatment
therapy 77 84 1428 1435 I-treatment
and/or 85 91 1436 1442 O
surgery 92 99 1443 1450 B-treatment
are 100 103 1451 1454 O
allowed 104 111 1455 1462 O

Prior 0 5 1463 1468 O
to 6 8 1469 1471 O
study 9 14 1472 1477 O
entry 15 20 1478 1483 O
, 20 21 1483 1484 O
any 22 25 1485 1488 O
ECG 26 29 1489 1492 B-clinical_variable
abnormality 30 41 1493 1504 I-clinical_variable
at 42 44 1505 1507 O
screening 45 54 1508 1517 O
has 55 58 1518 1521 O
to 59 61 1522 1524 O
be 62 64 1525 1527 O
documented 65 75 1528 1538 O
by 76 78 1539 1541 O
the 79 82 1542 1545 O
investigator 83 95 1546 1558 O
as 96 98 1559 1561 O
not 99 102 1562 1565 O
medically 103 112 1566 1575 O
relevant 113 121 1576 1584 O

Serious 0 7 1585 1592 O
concomitant 8 19 1593 1604 O
systemic 20 28 1605 1613 B-chronic_disease
disorders 29 38 1614 1623 I-chronic_disease
( 39 40 1624 1625 O
e.g. 40 44 1625 1629 O
, 44 45 1629 1630 O
active 46 52 1631 1637 B-chronic_disease
uncontrolled 53 65 1638 1650 I-chronic_disease
infection 66 75 1651 1660 I-chronic_disease
or 76 78 1661 1663 O
uncontrolled 79 91 1664 1676 B-chronic_disease
diabetes 92 100 1677 1685 I-chronic_disease
) 100 101 1685 1686 O
or 102 104 1687 1689 O
psychiatric 105 116 1690 1701 B-chronic_disease
disorders 117 126 1702 1711 I-chronic_disease
that 127 131 1712 1716 O
, 131 132 1716 1717 O
in 133 135 1718 1720 O
the 136 139 1721 1724 O
opinion 140 147 1725 1732 O
of 148 150 1733 1735 O
the 151 154 1736 1739 O
investigator 155 167 1740 1752 O
, 167 168 1752 1753 O
would 169 174 1754 1759 O
compromise 175 185 1760 1770 O
the 186 189 1771 1774 O
safety 190 196 1775 1781 O
of 197 199 1782 1784 O
the 200 203 1785 1788 O
patient 204 211 1789 1796 O
or 212 214 1797 1799 O
compromise 215 225 1800 1810 O
the 226 229 1811 1814 O
patient 230 237 1815 1822 O
's 237 239 1822 1824 O
ability 240 247 1825 1832 O
to 248 250 1833 1835 O
complete 251 259 1836 1844 O
the 260 263 1845 1848 O
study 264 269 1849 1854 O

Uncontrolled 0 12 1855 1867 B-chronic_disease
diabetes 13 21 1868 1876 I-chronic_disease
mellitus 22 30 1877 1885 I-chronic_disease
defined 31 38 1886 1893 O
as 39 41 1894 1896 O
a 42 43 1897 1898 O
Hemoglobin 44 54 1899 1909 B-clinical_variable
A1Câ‰¥ 55 59 1910 1914 I-clinical_variable
10 60 62 1915 1917 B-lower_bound
% 62 63 1917 1918 I-lower_bound
in 64 66 1919 1921 O
patients 67 75 1922 1930 O
with 76 80 1931 1935 O
a 81 82 1936 1937 O
prior 83 88 1938 1943 O
history 89 96 1944 1951 O
of 97 99 1952 1954 O
diabetes 100 108 1955 1963 O
, 108 109 1963 1964 O
prior 110 115 1965 1970 O
to 116 118 1971 1973 O
study 119 124 1974 1979 O
enrollment 125 135 1980 1990 O

methotrexate 0 12 1991 2003 B-treatment
is 13 15 2004 2006 O
Pregnancy 16 25 2007 2016 B-pregnancy
Category 26 34 2017 2025 O
X 35 36 2026 2027 O
- 37 38 2028 2029 O
has 39 42 2030 2033 O
been 43 47 2034 2038 O
reported 48 56 2039 2047 O
to 57 59 2048 2050 O
cause 60 65 2051 2056 O
fetal 66 71 2057 2062 O
death 72 77 2063 2068 O
and/or 78 84 2069 2075 O
congenital 85 95 2076 2086 O
abnormalities 96 109 2087 2100 O

prior 0 5 2101 2106 B-treatment
use 6 9 2107 2110 I-treatment
of 10 12 2111 2113 I-treatment
systemic 13 21 2114 2122 I-treatment
methotrexate 22 34 2123 2135 I-treatment
> 35 36 2136 2137 O
1 37 38 2138 2139 B-lower_bound
month 39 44 2140 2145 I-lower_bound
prior 45 50 2146 2151 I-lower_bound
to 51 53 2152 2154 O
study 54 59 2155 2160 O
entry 60 65 2161 2166 O
is 66 68 2167 2169 O
allowed 69 76 2170 2177 O

